Amneal Pharmaceuticals News - AMRX

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Amneal Pharmaceuticals Inc AMRX NYSE Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 2.72 0.00 0.00 0.00 2.72 05:47:58
more quote information »

Recent News

Date Time Source Heading
10/11/201916:42EDGARProxy Statement - Other Information (preliminary) (pre 14c)
10/11/201912:08EDGARCurrent Report Filing (8-k)
10/10/201909:25BWAmneal Announces Launch of Generic Invega®
10/09/201908:30BWAmneal to Report Third Quarter 2019 Results on November 6,..
9/11/201917:15EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
9/10/201912:14EDGARAmended Statement of Ownership (sc 13g/a)
9/05/201909:25BWAmneal Announces Approval of Generic Version of Amicar®
9/03/201908:35BWAmneal Pharmaceuticals to Present at the Morgan Stanley 17th..
8/28/201916:54EDGARStatement of Changes in Beneficial Ownership (4)
8/26/201917:28EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
8/26/201917:28EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
8/08/201906:16EDGARStatement of Changes in Beneficial Ownership (4)
8/07/201916:33EDGARStatement of Changes in Beneficial Ownership (4)
8/07/201908:58EDGARStatement of Changes in Beneficial Ownership (4)
8/07/201906:05EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
8/07/201906:01EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
8/06/201916:27EDGARStatement of Changes in Beneficial Ownership (4)
8/06/201916:20EDGARInitial Statement of Beneficial Ownership (3)
8/05/201916:41EDGARQuarterly Report (10-q)
8/05/201906:20EDGARCurrent Report Filing (8-k)
8/05/201906:20EDGARCurrent Report Filing (8-k)
8/05/201906:01BWAmneal Reports Second Quarter 2019 Financial Results
8/05/201906:00BWAmneal Pharmaceuticals Co-Founders Chirag Patel and Chintu..
7/22/201911:36DJNFDA Approves Multiple Applications for Generic Version of..
7/22/201907:00BWAmneal Announces Launch of Generic Lyrica®
7/19/201916:51EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
7/19/201916:48EDGARInitial Statement of Beneficial Ownership (3)
7/10/201916:53EDGARCurrent Report Filing (8-k)
7/10/201906:45BWAmneal Pharmaceuticals Announces Restructuring & Costs..
7/09/201908:45BWAmneal to Report Second Quarter 2019 Results on August 8,..
6/06/201908:35BWAmneal Pharmaceuticals to Present at Upcoming Investor..
5/16/201917:01EDGARStatement of Changes in Beneficial Ownership (4)
5/15/201909:25BWAmneal Pharmaceuticals to Present at the RBC Capital Markets..
5/13/201917:29EDGARStatement of Changes in Beneficial Ownership (4)
5/13/201917:29EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201917:47EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201917:46EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201917:46EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201917:45EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201917:44EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201916:54EDGARCurrent Report Filing (8-k)
5/09/201906:43EDGARCurrent Report Filing (8-k)
5/09/201906:30BWAmneal Reports First Quarter 2019 Financial Results
5/08/201917:51EDGARStatement of Changes in Beneficial Ownership (4)
5/08/201917:51EDGARStatement of Changes in Beneficial Ownership (4)
5/08/201917:51EDGARStatement of Changes in Beneficial Ownership (4)
5/08/201917:50EDGARStatement of Changes in Beneficial Ownership (4)
5/08/201917:49EDGARStatement of Changes in Beneficial Ownership (4)
5/08/201917:49EDGARStatement of Changes in Beneficial Ownership (4)
5/08/201917:48EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »
Your Recent History
NYSE
AMRX
Amneal Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191014 12:52:33